Event Date: 13 May 2019 to 14 May 2019

SMi’s 19th Annual Pain Therapeutics Conference

Event Notes:

Proudly sponsored by: CHDR, Lotus Clinical Research and MD Biosciences. Discover the latest Innovations in Analgesic Therapies. The global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, postsurgical pain, arthritis, and fibromyalgia, is driving growth. Join Europe's leading Pain Therapeutics Conference, to explore the cutting-edge research of novel therapeutic targets in the pipeline of leading pharmaceutical companies and to discuss solutions for the challenges of clinical trial design and conduct. The 19th annual conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, atypical opioids, migraine treatments, such as Lasmiditan and Aimovig, novel discoveries in opioid-free analgesia and the future forecast for pain therapeutics – industry leaders will uncover the latest advancements in the field. Furthermore, policy experts will provide an essential regulatory perspective for this year’s agenda, providing an exciting and comprehensive insight into the pain therapeutics market. New case studies and regulatory perspectives will bring together the challenges and successes of both pre-clinical and clinical development to equip you with the necessary knowledge to advance the pain therapeutic industry. WHO SHOULD ATTEND: Chief Executive Officer, Chief Scientific Officers, Chief Medical Officers, Managing Directors, CEO, Head of Department, Principal Research Scientists, Clinical lead, Clinical Operations in the following fields: Pain and Migraine; Inflammation; Chronic Pain; Neuropathic Pain; Analgesic pre-clinical development; Anaesthesia and Pain Management; CNS clinical trials; Ion Channel Pharmacology; Pharmacology Intelligence; Translational science; Drug development; Exploratory development.

SIGN UP FOR OUR MAILING LIST

Open Access, for medical professionals: Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified. 

We may infrequently send you news from our sponsors which is relevant to the field of neurology, but you can opt out at any time.

See a sample email newsletter here
This website is for medical professionals only.